HEDS is part of the School of Health and Related Research (ScHARR) at the University of Sheffield. We undertake research, teaching, training and consultancy on all aspects of health related decision science, with a particular emphasis on health economics, HTA and evidence synthesis.

Thursday, 22 December 2011

Recently published CUAs

Twice each month the CEA Registry Blog lists recently published cost utility studies and associated papers.  40 papers were listed this time. Here's a handful in our areas of research interest:

Soini E, Hallinen T, Puolakka K, et al. Cost-effectiveness of adalimumab, etanercept and tocilizumab as first-line treatments for moderate-to-severe rheumatoid arthritis. J Med Econ. 2011 Dec 14. [Epub ahead of  print] PubMed PMID: 22168785.

Hoogendoorn M, Rutten-van Mölken MP, Hoogenveen RT, et al. Developing and applying a stochastic dynamic population model for chronic obstructive pulmonary disease. Value Health. 2011 Dec;14(8):1039-47. PMID: 22152172.

Hall PS, McCabe C, Stein RC, Cameron D. Economic Evaluation of Genomic Test-Directed Chemotherapy for Early-Stage Lymph Node-Positive Breast Cancer. J Natl Cancer Inst. 2011 Dec 2. [Epub ahead of print] PMID: 22138097.

Tran-Duy A, Boonen A, van de Laar MA, et al. A discrete event modelling framework for simulation of long-term outcomes of sequential treatment strategies for ankylosing spondylitis. Ann Rheum Dis. 2011 Dec;70(12):2111-8.  PMID: 21857027.